An oral HIV drug helped patients with center-involved diabetic macular edema achieve improvements in visual acuity, according to a study in Med.
Jayakrishna Ambati, MD, and colleagues evaluated lamivudine, an antiviral drug typically used for the treatment of HIV, in 24 patients with DME. Ambati said an oral drug would be a game-changer for DME management.
“The standard of care for diabetic macular edema, which affects millions of people around the world, is monthly intravitreous injections of anti-VEGF drugs,” he said. “While they are effective at improving vision, these drugs require frequent